![Flavia Borellini](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Flavia Borellini
Director/Board Member at
REVOLUTION MEDICINES, INC.
Net worth: 4 M $ as of 2026-05-30
Profile
Flavia Borellini currently serves as Independent Director at Cantargia AB since 2020, Independent Director at Revolution Medicines, Inc. since 2021, Director at Kartos Therapeutics, Inc. since 2018, and as a Member of Roche Group.
Former roles include Chief Executive Officer at Acerta Pharma BV from 2016 to 2019, Independent Director at Viracta Therapeutics, Inc. from 2021 to 2025, VP-Global Product & Portfolio Strategy at AstraZeneca PLC from 2018 to 2020, and Vice President-Program Leadership at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
Education includes a doctorate from Università degli Studi di Modena e Reggio Emilia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-17 | 26,215 ( 0.01% ) | 4 M $ | 2026-05-30 |
Flavia Borellini active positions
| Companies | Position | Start |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Director/Board Member | 2021-06-21 |
| CANTARGIA AB | Director/Board Member | 2020-09-30 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company | Director/Board Member | 2018-01-31 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | - |
Former positions of Flavia Borellini
| Companies | Position | End |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2025-02-04 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2019-12-31 |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Chief Executive Officer | 2019-01-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2013-09-30 |
Training of Flavia Borellini
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
Università degli Studi di Modena e Reggio Emilia
 Università degli Studi di Modena e Reggio Emilia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
Revolution Medicines, Inc.
 Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
- Stock Market
- Insiders
- Flavia Borellini
